16.01.2013 13:20 Uhr, Quelle: Wallstreet online

New Treatment for Paediatric Crohn´s Disease Now Available in the UK

MAIDENHEAD, England, January 16, 2013 /PRNewswire/ HUMIRA(R) (adalimumab) is the first biologic treatment in more than five years to be approved in the European Union for the treatment of severe active paediatric Crohn´s disease offering …

Weiterlesen bei Wallstreet online